Mercer Global Advisors
ALT icon

Mercer Global Advisors’s Altimmune ALT Stock Holding History

Mercer Global Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
+53,115
New +$159K ﹤0.01% 3317
2025
Q3 		– Sell
-12,868
Closed -$49.8K – 2639
2025
Q2 		$49.8K Buy
12,868
+2,121
+20% +$11.5K ﹤0.01% 2200
2025
Q1 		$53.7K Buy
+10,747
New +$68.1K ﹤0.01% 2102

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's ALT Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Altimmune (ALT) in Q2 2026: 53,115 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #3317 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in ALT as recently as Q2 2025.

Mercer Global Advisors first reported a position in ALT in Q1 2025 and has held it in 3 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Mercer Global Advisors held 53,115 shares of Altimmune worth $161K as of Q2 2026.
  • Altimmune was a new Mercer Global Advisors position in Q2 2026.
  • Altimmune made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3317 holding.
  • Mercer Global Advisors first reported a position in Altimmune in Q1 2025 and has held it in 3 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.